Dosage Information for Harvoni: Forms, Potencies, Administration, and Additional Details
Harvoni is a brand-name drug, prescribed for hepatitis C in adults and some children. This medication comes in two oral forms: tablets and pellets in unit-dose packets.
Harvoni belongs to the drug class called direct-acting antivirals and is not meant to be taken as a long-term treatment. The duration of treatment depends on the hepatitis C virus genotype and liver function.
For adults, the recommended dosage is one 90 mg/400 mg tablet once per day. However, for children, the dosage is based on body weight. For example, children weighing between 17 to < 35 kg might be prescribed 33.75 mg ledipasvir / 150 mg sofosbuvir once daily, often provided as oral packets. Children weighing 35 kg and above typically receive the adult dose.
It's important to note that specific dosing guidelines for pediatric patients are not detailed in the provided search results. Therefore, it is crucial to consult official prescribing information or infectious disease specialists for precise pediatric Harvoni dosing based on body weight.
If you or your child has difficulty swallowing Harvoni pellets, they can be mixed with a small amount of non-acidic food. If you have trouble swallowing Harvoni tablets, there are tips available to help.
Harvoni is available in a generic version and can be taken at any time of day, but it may be helpful to take it at the same time each day. If you miss a dose, take it as soon as you remember, but do not take two doses to make up for the missed one.
It's essential to always follow the dosage that your doctor prescribes and never change it without their recommendation. If you take more than the recommended amount, call your doctor right away or contact America's Poison Centers.
Additional helpful resources include articles about more aspects of Harvoni, drug comparisons, cost information, and details about the condition that Harvoni treats. Some pharmacies offer labels with large print, braille, or a code you scan with a smartphone to convert text to speech.
Harvoni is used to treat hepatitis C in children ages 3 years and older. It's important to remember that every patient's situation is unique, and the best course of treatment can only be determined by a medical professional. Always consult with a healthcare provider before taking any medication.
- Children requiring Harvoni treatment often receive a dose based on their body weight, with those between 17 to < 35 kg typically prescribed 33.75 mg ledipasvir / 150 mg sofosbuvir once daily.
- The use of Harvoni extends to children aged 3 years and older, but specific dosing guidelines for pediatric patients are not always detailed in the provided search results.
- To help children or individuals who have difficulty swallowing Harvoni pellets, they can be mixed with a small amount of non-acidic food.
- It's important to note that Harvoni is part of the direct-acting antiviral drug class and is not recommended for long-term treatment, with the duration depending on the hepatitis C virus genotype and liver function.
